[{"address1": "455 East Medical Center Boulevard", "address2": "Suite 300", "city": "Houston", "state": "TX", "zip": "77598", "country": "United States", "phone": "281 671 5150", "website": "https://www.fibrobiologics.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for treating wound healing. Its early-stage research programs include CYTER915 which is designed to regenerate or reinvigorate production of the thymus and/or spleen; and TCB190 for the treatment of cancers. The company was incorporated in 2021 and is based in Houston, Texas.", "fullTimeEmployees": 10, "companyOfficers": [{"maxAge": 1, "name": "Mr. Peter  O'Heeron", "age": 59, "title": "Founder, Chairman & CEO", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 950723, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Hamid  Khoja Ph.D.", "age": 53, "title": "Chief Scientific Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 423119, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 10.4, "open": 10.96, "dayLow": 9.53, "dayHigh": 10.96, "regularMarketPreviousClose": 10.4, "regularMarketOpen": 10.96, "regularMarketDayLow": 9.53, "regularMarketDayHigh": 10.96, "volume": 42947, "regularMarketVolume": 42947, "averageVolume": 144908, "averageVolume10days": 73350, "averageDailyVolume10Day": 73350, "bidSize": 900, "askSize": 800, "marketCap": 324712288, "fiftyTwoWeekLow": 6.53, "fiftyTwoWeekHigh": 46.0, "fiftyDayAverage": 12.003913, "twoHundredDayAverage": 12.003913, "currency": "USD", "enterpriseValue": 316021088, "floatShares": 24692347, "sharesOutstanding": 32634400, "dateShortInterest": 1707955200, "heldPercentInsiders": 0.30412, "shortRatio": 0.36, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -19058000, "enterpriseToEbitda": -35.741, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "FBLG", "underlyingSymbol": "FBLG", "shortName": "FibroBiologics, Inc.", "longName": "FibroBiologics, Inc.", "firstTradeDateEpochUtc": 1706797800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "6752a379-a671-33c4-8602-9f32d42c8f6a", "gmtOffSetMilliseconds": -18000000, "currentPrice": 9.95, "recommendationKey": "none", "totalCash": 9163000, "totalCashPerShare": 0.282, "ebitda": -8842000, "totalDebt": 1888000, "quickRatio": 0.998, "currentRatio": 1.003, "debtToEquity": 150.678, "returnOnAssets": -0.66753995, "freeCashflow": 3831500, "operatingCashflow": -6401000, "financialCurrency": "USD", "trailingPegRatio": null}]